Hyunju Yang1, Christopher G Engeland2,3, Tonya S King4, Amy M Sawyer5,6,7. 1. Chonnam National University, College of Nursing, Gwangju, South Korea. 2. The Pennsylvania State University, Department of Biobehavioral Health, University Park, Pennsylvania. 3. The Pennsylvania State University, College of Nursing, University Park, Pennsylvania. 4. The Pennsylvania State University, College of Medicine, Department of Public Health Sciences, Hershey, Pennsylvania. 5. University of Pennsylvania, School of Nursing, Philadelphia, Pennsylvania. 6. Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania. 7. University of Pennsylvania, Perelman School of Medicine, Center for Sleep & Circadian Neurobiology, Philadelphia, Pennsylvania.
Abstract
OBJECTIVES: To identify the relationship between (1) cytokines and everyday symptoms and (2) cytokine diurnal variation and everyday symptoms in mild obstructive sleep apnea (OSA). METHODS: An observational, single-night study of 20 adults with mild to moderate OSA undergoing diagnostic polysomnography. Everyday symptoms included sleepiness measured by Stanford Sleepiness Scale, fatigue and energy levels measured by Lee Fatigue Scale, and cytokine plasma concentrations including interleukin (IL)-1β, IL-6, IL-8, and tumor necrosis factor-α (TNF-α) measured concurrent with symptoms at presleep (8 pm to 10 pm; time 1) and postsleep (5 am to 6 am; time. 2) Cytokine diurnal variation was calculated as [time 2 - time 1]. Wilcoxon signed-rank tests and Spearman partial rank correlations adjusted for age, body mass index, cardiovascular disease, and type 2 diabetes were used. RESULTS: Twenty patients (50% male, obese, median age = 51.0 years) with mild OSA (apnea-hypopnea index, AHI; median 9.5 events/h) were evaluated. Evening IL-6 was associated with evening symptoms, including sleepiness (r = .69, P = .002) and energy level (r = -0.68, P = .003); morning IL-8 (r = .73, P = .001), and TNF-α (r = .59, P = .015) were associated with morning fatigue. Only morning IL-8 (r = -0.57, P = .022) and diurnal variations in IL-8 (r = -0.60, P = .014) were associated with morning energy level. CONCLUSION: There is scant evidence addressing the diurnal variation of inflammatory biomarkers and the relationship with symptom expression in mild OSA. The present findings provide preliminary mechanistic findings for symptom expression in OSA and contribute insight to mild OSA symptom phenotypes.
OBJECTIVES: To identify the relationship between (1) cytokines and everyday symptoms and (2) cytokine diurnal variation and everyday symptoms in mild obstructive sleep apnea (OSA). METHODS: An observational, single-night study of 20 adults with mild to moderate OSA undergoing diagnostic polysomnography. Everyday symptoms included sleepiness measured by Stanford Sleepiness Scale, fatigue and energy levels measured by Lee Fatigue Scale, and cytokine plasma concentrations including interleukin (IL)-1β, IL-6, IL-8, and tumor necrosis factor-α (TNF-α) measured concurrent with symptoms at presleep (8 pm to 10 pm; time 1) and postsleep (5 am to 6 am; time. 2) Cytokine diurnal variation was calculated as [time 2 - time 1]. Wilcoxon signed-rank tests and Spearman partial rank correlations adjusted for age, body mass index, cardiovascular disease, and type 2 diabetes were used. RESULTS: Twenty patients (50% male, obese, median age = 51.0 years) with mild OSA (apnea-hypopnea index, AHI; median 9.5 events/h) were evaluated. Evening IL-6 was associated with evening symptoms, including sleepiness (r = .69, P = .002) and energy level (r = -0.68, P = .003); morning IL-8 (r = .73, P = .001), and TNF-α (r = .59, P = .015) were associated with morning fatigue. Only morning IL-8 (r = -0.57, P = .022) and diurnal variations in IL-8 (r = -0.60, P = .014) were associated with morning energy level. CONCLUSION: There is scant evidence addressing the diurnal variation of inflammatory biomarkers and the relationship with symptom expression in mild OSA. The present findings provide preliminary mechanistic findings for symptom expression in OSA and contribute insight to mild OSA symptom phenotypes.
Authors: Vishesh K Kapur; Dennis H Auckley; Susmita Chowdhuri; David C Kuhlmann; Reena Mehra; Kannan Ramar; Christopher G Harrod Journal: J Clin Sleep Med Date: 2017-03-15 Impact factor: 4.062
Authors: Johanna Sahlman; Kati Miettinen; Keijo Peuhkurinen; Juha Seppä; Markku Peltonen; Christian Herder; Kari Punnonen; Esko Vanninen; Helena Gylling; Markku Partinen; Matti Uusitupa; Henri Tuomilehto Journal: J Sleep Res Date: 2009-12-16 Impact factor: 3.981
Authors: Felipe Almeida Mendes; Silvio Antonio Monteiro Marone; Bruno Bernardo Duarte; Ana Carolina Parsekian Arenas Journal: Int Arch Otorhinolaryngol Date: 2014-02-28